| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate |
2010-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480ac056831ce998b67f0ef2f5f178b1 |
| publicationDate |
2010-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010316590-A1 |
| titleOfInvention |
Compositions and methods related to poloxamer copolymer membrane sealant |
| abstract |
Embodiments of the invention include the treatment of amyloid oligomer toxicity by administering a membrane sealant co-polymer, for example poloxamer 188 (P188). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3747448-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104027349-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11155679-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10501577-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013026060-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016007537-A1 |
| priorityDate |
2009-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |